Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Marco Giannoccaro"'
Autor:
Graziano Santoro, Cristina Lapucci, Marco Giannoccaro, Simona Caporilli, Martina Rusin, Anna Seidenari, Maurizio Ferrari, Antonio Farina
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 2108 (2021)
The present pilot study investigates whether an abnormal miRNA profile in NIPT plasma samples can explain the finding of a low cell-free DNA (cfDNA) fetal fraction (cfDNAff) in euploid fetuses and non-obese women. Twelve women who underwent neoBona®
Externí odkaz:
https://doaj.org/article/2a8e843759b243ffb7628b3a5e8c65e1
Autor:
Francesco Serafini, Luca Bonanni, Andrea Zancanaro, Giuseppina Fricano, Marco Giannoccaro, Elisa Zulian, Michele Dalla Vestra, Paola Atanasio, Pierantonio Conton, Carlo De Riva, Giuseppe Fantin, Fabio Presotto
Publikováno v:
Italian Journal of Medicine, Vol 6, Iss 3 (2012)
Introduction The analysis of the production related to health care activities in the Medicine ward of dell’Angelo Hospital (Mestre-Venezia, Italy) in the year 2010 reveals that the short-term hospitalization, less than 3 days, corresponds to 18% of
Externí odkaz:
https://doaj.org/article/bc6e05d4867b4a01913220ffb1b13cd8
Autor:
Loris De Cecco, Silvana Canevari, Lisa Licitra, Laura D. Locati, Silvana Pilotti, Federica Perrone, Barbara Cortelazzi, Edoardo Marchesi, Marco Giannoccaro, Federica Favales, Andrea P. Sponghini, Maria Cossu Rocca, Marco Siano, Cristiana Bergamini, Paolo Bossi
Fig S2. Technical validation using NuGEN's Ovation System. The scatter plot shows the fold change consistency of genes differentially expressed using WG-DASL and NuGEN methods. Only 6 out of the 509 DE genes were found discordant, confirming the WG-D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07c1521837d8735544ec5a5971a5bdf
https://doi.org/10.1158/1078-0432.22455138
https://doi.org/10.1158/1078-0432.22455138
Autor:
Loris De Cecco, Silvana Canevari, Lisa Licitra, Laura D. Locati, Silvana Pilotti, Federica Perrone, Barbara Cortelazzi, Edoardo Marchesi, Marco Giannoccaro, Federica Favales, Andrea P. Sponghini, Maria Cossu Rocca, Marco Siano, Cristiana Bergamini, Paolo Bossi
Fig S1. Volcano plot for the 17,378 genes detected by microarray analysis. The x-axis is the fold-change, and the y-axis is log10 p value. A total of 509 probes (blue dots) were differentially expressed in long-PFS patients (14) compared with short-P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34bbd01208fe38f28ae4e75cc51e8d56
https://doi.org/10.1158/1078-0432.22455141.v1
https://doi.org/10.1158/1078-0432.22455141.v1
Autor:
Loris De Cecco, Silvana Canevari, Lisa Licitra, Laura D. Locati, Silvana Pilotti, Federica Perrone, Barbara Cortelazzi, Edoardo Marchesi, Marco Giannoccaro, Federica Favales, Andrea P. Sponghini, Maria Cossu Rocca, Marco Siano, Cristiana Bergamini, Paolo Bossi
FigS3: Biasogram representing the influence of tissue origin on outcome. Y axes indicate the outcome vector (long- versus short- PFS), while B indicates the nuisance variable (tissue origin; primary versus recurrence/metastatic). The colorgram repres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77bab4e61f992b12e2f8b497435ca156
https://doi.org/10.1158/1078-0432.22455135
https://doi.org/10.1158/1078-0432.22455135
Autor:
Loris De Cecco, Silvana Canevari, Lisa Licitra, Laura D. Locati, Silvana Pilotti, Federica Perrone, Barbara Cortelazzi, Edoardo Marchesi, Marco Giannoccaro, Federica Favales, Andrea P. Sponghini, Maria Cossu Rocca, Marco Siano, Cristiana Bergamini, Paolo Bossi
Purpose: To identify the tumor portrait of the minority of head and neck squamous cell carcinoma (HNSCC) patients with recurrent–metastatic (RM) disease who upon treatment with platinum-based chemotherapy plus cetuximab present a long-lasting respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1da047f43ec3b38607fca1827ca3599e
https://doi.org/10.1158/1078-0432.c.6522930.v1
https://doi.org/10.1158/1078-0432.c.6522930.v1
Autor:
Loris De Cecco, Silvana Canevari, Lisa Licitra, Laura D. Locati, Silvana Pilotti, Federica Perrone, Barbara Cortelazzi, Edoardo Marchesi, Marco Giannoccaro, Federica Favales, Andrea P. Sponghini, Maria Cossu Rocca, Marco Siano, Cristiana Bergamini, Paolo Bossi
Fig S4. Ability of existing gene signatures to predict outcome following cetuximab treatment. Five available prognostic gene-expression based signatures were taken into account: i) the hypoxia metagene (Winter, 2007); ii) the 13-gene OSCC signature (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9466d780ea76bd52e357fe1e0dec8065
https://doi.org/10.1158/1078-0432.22455132.v1
https://doi.org/10.1158/1078-0432.22455132.v1
Autor:
Loris De Cecco, Silvana Canevari, Lisa Licitra, Laura D. Locati, Silvana Pilotti, Federica Perrone, Barbara Cortelazzi, Edoardo Marchesi, Marco Giannoccaro, Federica Favales, Andrea P. Sponghini, Maria Cossu Rocca, Marco Siano, Cristiana Bergamini, Paolo Bossi
Supplementary Table S2 Gene sets associated to long- and short-PFS patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::770eb1544e2b03b9c486e9773baa52cd
https://doi.org/10.1158/1078-0432.22455126.v1
https://doi.org/10.1158/1078-0432.22455126.v1
Autor:
Simona Caporilli, Antonio Farina, Maurizio Ferrari, Cristina Lapucci, Marco Giannoccaro, Anna Seidenari, Martina Rusin, Graziano Santoro
Publikováno v:
Diagnostics, Vol 11, Iss 2108, p 2108 (2021)
Diagnostics
Diagnostics
The present pilot study investigates whether an abnormal miRNA profile in NIPT plasma samples can explain the finding of a low cell-free DNA (cfDNA) fetal fraction (cfDNAff) in euploid fetuses and non-obese women. Twelve women who underwent neoBona®
Autor:
Barbara Cortelazzi, Laura D. Locati, Silvana Canevari, Marco Giannoccaro, Andrea Pietro Sponghini, Federica Perrone, Cristiana Bergamini, Edoardo Marchesi, M. Siano, Federica Favales, Maria Cossu Rocca, Lisa Licitra, Silvana Pilotti, Paolo Bossi, Loris De Cecco
Publikováno v:
Clinical Cancer Research. 22:3961-3970
Purpose: To identify the tumor portrait of the minority of head and neck squamous cell carcinoma (HNSCC) patients with recurrent–metastatic (RM) disease who upon treatment with platinum-based chemotherapy plus cetuximab present a long-lasting respo